Role of tumor microenvironment in tumorigenesis

Tumorigenesis is a complex and dynamic process, consisting of three stages: initiation, progression, and metastasis. Tumors are encircled by extracellular matrix (ECM) and stromal cells, and the physiological state of the tumor microenvironment (TME) is closely connected to every step of tumorigenesis. Evidence suggests that the vital components of the TME are fibroblasts and myofibroblasts, neuroendocrine cells, adipose cells, immune and inflammatory cells, the blood and lymphatic vascular networks, and ECM. This manuscript, based on the current studies of the TME, offers a more comprehensive overview of the primary functions of each component of the TME in cancer initiation, progression, and invasion. The manuscript also includes primary therapeutic targeting markers for each player, which may be helpful in treating tumors.

[1]  Z. Zeng,et al.  Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. , 2007, Human pathology.

[2]  J. Lederer,et al.  Targeting regulatory T cells in cancer. , 2011, Cancer research.

[3]  Robert Axelrod,et al.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. , 2008, Translational oncology.

[4]  P. A. Sant'agnese,et al.  Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. , 1992 .

[5]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[6]  Albert D Donnenberg,et al.  Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. , 2011, Tissue engineering. Part A.

[7]  P. di Sant'Agnese,et al.  Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications , 1992, Cancer.

[8]  V. Gocheva,et al.  Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development , 2012, Oncogene.

[9]  W. Jung,et al.  Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells , 2015, Breast Cancer Research and Treatment.

[10]  S. Lehmann,et al.  Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. , 2008, Experimental cell research.

[11]  P. Singh,et al.  Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. , 1986, Cellular immunology.

[12]  Zhifeng Xue,et al.  Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis , 2015, Rheumatology International.

[13]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[14]  C. Cursiefen,et al.  Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye? , 2015, Seminars in cell & developmental biology.

[15]  S. Steinshamn,et al.  Expression of neuroendocrine markers in non‐small cell lung cancer , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[16]  D. Winer,et al.  The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance , 2012, Immunology and cell biology.

[17]  C. Davis,et al.  Molecular targets for nutritional preemption of cancer. , 2007, Current cancer drug targets.

[18]  Z. Zeng,et al.  Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma , 2013, Journal of Molecular Histology.

[19]  Yao‐Hua Song,et al.  Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. , 2009, Cancer letters.

[20]  E. Middleton,et al.  Effects of flavonoids on immune and inflammatory cell functions. , 1992, Biochemical pharmacology.

[21]  Xiaoling Li,et al.  Progress of Long Noncoding RNA HOTAIR in Human Cancer , 2015 .

[22]  P. Goodwin Obesity and endocrine therapy: host factors and breast cancer outcome. , 2013, Breast.

[23]  T. Akhurst,et al.  Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  C. Addey,et al.  Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy , 2010, Cancer Immunology, Immunotherapy.

[25]  V. Christiaens,et al.  Angiogenesis and development of adipose tissue , 2010, Molecular and Cellular Endocrinology.

[26]  Zena Werb,et al.  Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.

[27]  M. Kolonin,et al.  Combinatorial stem cell mobilization , 2009, Nature Biotechnology.

[28]  Jia Huang,et al.  Different roles of myofibroblasts in the tumorigenesis of nonsmall cell lung cancer , 2016, Tumor Biology.

[29]  J. Jung,et al.  MBD6 is a direct target of Oct4 and controls the stemness and differentiation of adipose tissue-derived stem cells , 2012, Cellular and Molecular Life Sciences.

[30]  L. Ellis,et al.  VEGF-targeted therapy: mechanisms of anti-tumour activity , 2008, Nature Reviews Cancer.

[31]  M. Levite Nerve‐Driven Immunity: The Direct Effects of Neurotransmitters on T‐Cell Function , 2000, Annals of the New York Academy of Sciences.

[32]  A. Ghaderi,et al.  Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response? , 2011, Cellular immunology.

[33]  Mark J. Smyth,et al.  Cancer immunoediting by the innate immune system in the absence of adaptive immunity , 2012, The Journal of experimental medicine.

[34]  L. Villani,et al.  Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling , 2013, Oncotarget.

[35]  W. Aulitzky,et al.  Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts , 2010, Molecular Cancer.

[36]  Y. Doki,et al.  miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts. , 2015, Carcinogenesis.

[37]  H. Kamma,et al.  PROX1 Promotes Secretory Granule Formation in Medullary Thyroid Cancer Cells. , 2016, Endocrinology.

[38]  Eelco F. J. Meijer,et al.  The Lymphatic System in Disease Processes and Cancer Progression. , 2016, Annual review of biomedical engineering.

[39]  Ji-Hye Park,et al.  Expression of Follicular Helper T-cell Markers in Primary Cutaneous T-cell Lymphoma , 2014, The American Journal of dermatopathology.

[40]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[41]  J. H. Kim,et al.  Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth. , 2012, The international journal of biochemistry & cell biology.

[42]  R. Matusik,et al.  NE-10 Neuroendocrine Cancer Promotes the LNCaP Xenograft Growth in Castrated Mice , 2004, Cancer Research.

[43]  L. Woolner,et al.  Pulmonary fibrosis. , 1954, The Medical clinics of North America.

[44]  B. Hennessy,et al.  Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors , 2011, Cellular Oncology.

[45]  Michael Simons,et al.  Branching morphogenesis. , 2008, Circulation research.

[46]  Z. Zeng,et al.  Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas , 2014, Science China Life Sciences.

[47]  Z. Zeng,et al.  Knockout of BRD7 results in impaired spermatogenesis and male infertility , 2016, Scientific Reports.

[48]  A. Giuliano,et al.  Selective Modulation of Paracortical Dendritic Cells and T‐Lymphocytes in Breast Cancer Sentinel Lymph Nodes , 2000, The breast journal.

[49]  Michael C. Ostrowski,et al.  Reprogramming of the Tumor Microenvironment by Stromal Pten-regulated miR-320 , 2011, Nature Cell Biology.

[50]  Z. Zeng,et al.  Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma , 2015, Oncotarget.

[51]  E. Tsilibary,et al.  Type IV collagen-mediated melanoma cell adhesion and migration: involvement of multiple, distinct domains of the collagen molecule. , 1989, Cancer research.

[52]  H. Hong Bioinformatics Accelerates Drug Repositioning , 2012 .

[53]  C. Rudin,et al.  A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo , 2015, Science Translational Medicine.

[54]  W. Xiong,et al.  miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma , 2016, Cell Death and Disease.

[55]  M. Yashiro,et al.  Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer. , 2016, World journal of gastroenterology.

[56]  K. Zänker,et al.  Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. , 2003, Immunology letters.

[57]  C. Shuai,et al.  Downregulation of Microrna‐148a in Cancer‐Associated Fibroblasts from Oral Cancer Promotes Cancer Cell Migration and Invasion by Targeting Wnt10b , 2016, Journal of biochemical and molecular toxicology.

[58]  A. Grossman,et al.  The diagnosis and medical management of advanced neuroendocrine tumors. , 2004, Endocrine reviews.

[59]  E. Clementi,et al.  Inflammatory and alternatively activated human macrophages attract vessel‐associated stem cells, relying on separate HMGB1‐ and MMP‐9‐dependent pathways , 2009, Journal of leukocyte biology.

[60]  K. Mills,et al.  Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines , 2014, Oncogene.

[61]  F. Cappuzzo,et al.  Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. , 2015, The Lancet. Oncology.

[62]  A. Mantovani,et al.  Molecular pathways linking inflammation and cancer. , 2010, Current molecular medicine.

[63]  Wei Xiong,et al.  Integrating ChIP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network , 2015, Molecular and Cellular Biochemistry.

[64]  J. Huot,et al.  Role of Cancer Microenvironment in Metastasis: Focus on Colon Cancer , 2008, Cancer Microenvironment.

[65]  Z. Zeng,et al.  Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma , 2016, Oncotarget.

[66]  Derek S. Chan,et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.

[67]  L. Kvols,et al.  GEPNETs update: Radionuclide therapy in neuroendocrine tumors. , 2014, European journal of endocrinology.

[68]  R. Kaarteenaho,et al.  Lung Cancer–Associated Myofibroblasts Reveal Distinctive Ultrastructure and Function , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[69]  Eun Hye Lim,et al.  Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. , 2011, Gynecologic oncology.

[70]  P. Kiely,et al.  Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells , 2014, Bioscience reports.

[71]  M. Longaker,et al.  TWIST1 Silencing Enhances In Vitro and In Vivo Osteogenic Differentiation of Human Adipose‐Derived Stem Cells by Triggering Activation of BMP‐ERK/FGF Signaling and TAZ Upregulation , 2015, Stem cells.

[72]  E. Jordanova,et al.  In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages , 2010, The Journal of Immunology.

[73]  Y. Son,et al.  Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury , 2013, Neuroreport.

[74]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[75]  G. Hu,et al.  New horizons in tumor microenvironment biology: challenges and opportunities , 2015, BMC Medicine.

[76]  R. Medzhitov,et al.  Stress, inflammation, and defense of homeostasis. , 2014, Molecular cell.

[77]  J. Shimazaki,et al.  Progression of prostate cancer to neuroendocrine cell tumor , 2001, International journal of urology : official journal of the Japanese Urological Association.

[78]  Z. Zeng,et al.  Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma , 2017, Oncotarget.

[79]  M. Karin,et al.  The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. , 2008, Trends in molecular medicine.

[80]  V. Parietti,et al.  Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. , 2008, Arthritis and rheumatism.

[81]  S. Albelda,et al.  Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response1 , 2007, The Journal of Immunology.

[82]  M. Bissell,et al.  Three-dimensional cultures of mouse mammary epithelial cells. , 2013, Methods in molecular biology.

[83]  P. Scherer,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0580 Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis , 2022 .

[84]  S. Kapitanović,et al.  IL-2 −330 T/G SNP and serum values—potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs) , 2010, Journal of Molecular Medicine.

[85]  Wei Xiong,et al.  MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A , 2016, Oncotarget.

[86]  V. Kosma,et al.  High numbers of macrophages, especially M2‐like (CD163‐positive), correlate with hyaluronan accumulation and poor outcome in breast cancer , 2015, Histopathology.

[87]  A. Calvo,et al.  The diffuse endocrine system: from embryogenesis to carcinogenesis. , 2003, Progress in histochemistry and cytochemistry.

[88]  Z. Zeng,et al.  Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1 , 2016, Oncotarget.

[89]  P. Goodwin,et al.  Impact of the obesity epidemic on cancer. , 2015, Annual review of medicine.

[90]  G. Mantovani,et al.  Adipose tissue as target organ in the treatment of hormone‐dependent breast cancer: new therapeutic perspectives , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[91]  Z. Zeng,et al.  LPLUNC1 Inhibits Nasopharyngeal Carcinoma Cell Growth via Down-Regulation of the MAP Kinase and Cyclin D1/E2F Pathways , 2013, PloS one.

[92]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[93]  Z. Zeng,et al.  Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[94]  Kenneth J. Pienta,et al.  Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis , 2013, Nature Communications.

[95]  Z. Zeng,et al.  A Susceptibility Locus at Chromosome 3p21 Linked to Familial Nasopharyngeal Carcinoma , 2004, Cancer Research.

[96]  P. Carmeliet,et al.  Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. , 2011, Current opinion in genetics & development.

[97]  Lei Cui,et al.  FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells , 2016, Tumor Biology.

[98]  Z. Zeng,et al.  Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays , 2012, Journal of Molecular Histology.

[99]  P. Bonaldo,et al.  Extracellular matrix: A dynamic microenvironment for stem cell niche , 2014, Biochimica et biophysica acta.

[100]  J. Maple,et al.  Yeast two-hybrid screening. , 2007, Methods in molecular biology.

[101]  P. Vlachostergios,et al.  Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives , 2015, Front. Oncol..

[102]  E. Simpson,et al.  Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[103]  J. Slingerland,et al.  Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. , 2013, Annual review of medicine.

[104]  P. Black,et al.  Growth Factors in Glioma Angiogenesis: FGFs, PDGF, EGF, and TGFs , 2000, Journal of Neuro-Oncology.

[105]  Sang-Ah Lee,et al.  Obesity related adipokines and colorectal cancer: a review and meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[106]  J. Granneman,et al.  Adipose tissue plasticity from WAT to BAT and in between. , 2014, Biochimica et biophysica acta.

[107]  Y. Miao,et al.  Galectin-1 Secreted by Activated Stellate Cells in Pancreatic Ductal Adenocarcinoma Stroma Promotes Proliferation and Invasion of Pancreatic Cancer Cells: An In Vitro Study on the Microenvironment of Pancreatic Ductal Adenocarcinoma , 2011, Pancreas.

[108]  Liu Guiyuan,et al.  ChIP-seq: a New Technique for Genome-wide Profiling of Protein-DNA Interaction , 2013 .

[109]  A. Rossary,et al.  Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity. , 2015, Life sciences.

[110]  M. Gassmann,et al.  Constitutive upregulation of hypoxia-inducible factor-1α mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure , 2003, Oncogene.

[111]  V. Castronovo,et al.  Increased expression of galectin‐1 in carcinoma‐associated stroma predicts poor outcome in prostate carcinoma patients , 2001, The Journal of pathology.

[112]  Z. Zeng,et al.  LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation , 2014, Oncogene.

[113]  Ya Cao,et al.  Immunoglobulin Expression and Its Biological Significance in Cancer Cells , 2008, Cellular and Molecular Immunology.

[114]  Z. Zeng,et al.  High Expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma , 2017, Journal of Cancer.

[115]  Giulio Gabbiani,et al.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.

[116]  M. Yi,et al.  Nasopharyngeal carcinoma: Advances in genomics and molecular genetics , 2011, Science China Life Sciences.

[117]  A. Engström‐Làurent,et al.  Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. , 1985, Annals of the rheumatic diseases.

[118]  R. Sanz-Pamplona,et al.  Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information , 2014, Molecular oncology.

[119]  Xiaoling Li,et al.  Cloning and Functional Characterization of a Novel Long Non-coding RNA Gene Associated With Hepatocellular Carcinoma , 2014 .

[120]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[121]  J. Chambers,et al.  Production of Tumor Necrosis Factor-alpha, Interleukin 1-beta, Interleukin 2, and Interleukin 6 by rat leukocyte subpopulations after exposure to Substance P , 2003, Neuropeptides.

[122]  N. Ferrara,et al.  VEGF inhibition: insights from preclinical and clinical studies , 2008, Cell and Tissue Research.

[123]  C. Dive,et al.  Biological mechanisms linking obesity and cancer risk: new perspectives. , 2010, Annual review of medicine.

[124]  V. Thannickal,et al.  Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[125]  U. Jeschke,et al.  Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells. , 2016, Anticancer research.

[126]  Christian Fischer,et al.  FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.

[127]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[128]  J. Reynolds,et al.  The role of obesity in gastrointestinal cancer: evidence and opinion , 2014, Therapeutic advances in gastroenterology.

[129]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[130]  F. Autschbach,et al.  Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity1 , 2007, The Journal of Immunology.

[131]  C. Dinarello,et al.  Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. , 1986, The Journal of clinical investigation.

[132]  T. Padera,et al.  The lymph node microenvironment and its role in the progression of metastatic cancer. , 2015, Seminars in cell & developmental biology.

[133]  Tao Yin,et al.  Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment , 2016, Molecular medicine reports.

[134]  F. Maquart,et al.  Matrikines from basement membrane collagens: a new anti-cancer strategy. , 2014, Biochimica et biophysica acta.

[135]  R. Bicknell,et al.  Anticancer strategies involving the vasculature , 2009, Nature Reviews Clinical Oncology.

[136]  Gonghua Zhao Advances in microRNAs and TP53 Gene Regulatory Network , 2012 .

[137]  J. Klein,et al.  Gluteal and abdominal subcutaneous adipose tissue depots as stroma cell source: gluteal cells display increased adipogenic and osteogenic differentiation potentials , 2014, Experimental dermatology.

[138]  M. Chilosi,et al.  Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells , 2015, British Journal of Cancer.

[139]  R. Tomasini,et al.  Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.

[140]  W. Savino Neuroendocrine control of T cell development in mammals: role of growth hormone in modulating thymocyte migration , 2007, Experimental physiology.

[141]  K. McMasters,et al.  Transient T cell depletion causes regression of melanoma metastases , 2008, Journal of Translational Medicine.

[142]  G. Mantovani,et al.  Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives , 2010 .

[143]  Yong Li,et al.  Circular RNAs in human cancer , 2017, Molecular Cancer.

[144]  C. Betsholtz,et al.  Endothelial-mural cell signaling in vascular development and angiogenesis. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[145]  D. Bates,et al.  Lymphatic density and metastatic spread in human malignant melanoma , 2004, British Journal of Cancer.

[146]  Craig Murdoch,et al.  The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.

[147]  J. Vykoukal,et al.  Breast cancer cells attract the migration of adipose tissue-derived stem cells via the PDGF-BB/PDGFR-beta signaling pathway. , 2010, Biochemical and biophysical research communications.

[148]  Bairong Shen,et al.  Inflammatory stimuli promote growth and invasion of pancreatic cancer cells through NF-κB pathway dependent repression of PP2Ac , 2016, Cell cycle.

[149]  D. Hanahan,et al.  Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. , 2003, The Journal of clinical investigation.

[150]  S. Nathanson,et al.  Intraoperative Clinical Assessment and Pressure Measurements of Sentinel Lymph Nodes in Breast Cancer , 2013, Annals of Surgical Oncology.

[151]  H. Kawai,et al.  Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node. , 2006, Journal of immunology.

[152]  K. Alitalo,et al.  Vascular endothelial growth factor B, a novel growth factor for endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[153]  Z. Zeng,et al.  Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells , 2016, Journal of Cancer.

[154]  B. Corfe,et al.  Classification and functions of enteroendocrine cells of the lower gastrointestinal tract , 2011, International journal of experimental pathology.

[155]  Dangxia Zhou,et al.  Prognostic value of neuroendocrine markers for predicting survival in patients with small cell lung cancer , 2016 .

[156]  R. Zheng,et al.  Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes1 , 2008, The Journal of Immunology.

[157]  D. Betcher,et al.  Granulocyte macrophage colony-stimulating factor , 1991, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[158]  B. Carver Defining and Targeting the Oncogenic Drivers of Neuroendocrine Prostate Cancer. , 2016, Cancer cell.

[159]  N. Parekh,et al.  Obesity in cancer survival. , 2012, Annual review of nutrition.

[160]  James O. Jones,et al.  Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia , 2013, The Journal of experimental medicine.

[161]  P. Chambon,et al.  Efficient temporally‐controlled targeted mutagenesis in smooth muscle cells of the adult mouse , 2009, Genesis.

[162]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[163]  M. Uhrberg,et al.  Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance , 2016, Cancer Immunology, Immunotherapy.

[164]  T. Wheeler,et al.  Cancer-Related Axonogenesis and Neurogenesis in Prostate Cancer , 2008, Clinical Cancer Research.

[165]  Z. Zeng,et al.  Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray , 2006, Journal of Cancer Research and Clinical Oncology.

[166]  Wei Wang,et al.  Significance of the NOR1-FOXA1/HDAC2-Slug regulatory network in epithelial-mesenchymal transition of tumor cells , 2016, Oncotarget.

[167]  R. Gomer,et al.  Alternative origins of stroma in normal organs and disease. , 2012, Stem cell research.

[168]  Wei Wang,et al.  NOR1 Suppresses Cancer Stem‐Like Cells Properties of Tumor Cells via the Inhibition of the AKT‐GSK‐3β‐Wnt/β‐catenin‐ALDH1A1 Signal Circuit , 2017, Journal of cellular physiology.

[169]  Gary R. Grotendorst,et al.  Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[170]  Liyu Liu,et al.  Enhanced Invasion of Metastatic Cancer Cells via Extracellular Matrix Interface , 2015, PloS one.

[171]  A. Pourfathollah,et al.  Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model , 2016, Scientific Reports.

[172]  J. Weiss,et al.  Induction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer Cells , 2016, Front. Immunol..

[173]  A. Bode,et al.  Heterogeneity of aberrant immunoglobulin expression in cancer cells , 2011, Cellular and Molecular Immunology.

[174]  J. Gómez-Reino,et al.  Adipokines as novel modulators of lipid metabolism. , 2009, Trends in biochemical sciences.

[175]  E. Tutunea-Fatan,et al.  The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis , 2015, Molecular Cancer.

[176]  M. Bissell,et al.  The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. , 1993, Epithelial cell biology.

[177]  J. Galon,et al.  From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer. , 2013, Current opinion in immunology.

[178]  K. Reiss,et al.  Harnessing the power of the immune system via blockade of PD-1 and PD-L1: a promising new anticancer strategy. , 2014, Immunotherapy.

[179]  F. Entschladen,et al.  Tumor immune escape mechanisms: impact of the neuroendocrine system , 2006, Cancer Immunology, Immunotherapy.

[180]  K. Alitalo,et al.  A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. , 1996, The EMBO journal.

[181]  Toshihide Matsumoto,et al.  Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas , 2010, Pathology international.

[182]  Z. Zeng,et al.  An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma , 2016, Tumor Biology.

[183]  E. Jordanova,et al.  Detection of M2-macrophages in uveal melanoma and relation with survival. , 2011, Investigative ophthalmology & visual science.

[184]  Xiumin Wang,et al.  PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients , 2014, Cancer Immunology, Immunotherapy.

[185]  E. Ben-Jacob,et al.  Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine? , 2015, Front. Oncol..

[186]  J. Buckwalter,et al.  Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. , 2005, Osteoarthritis and cartilage.

[187]  R. Linnoila Functional facets of the pulmonary neuroendocrine system , 2006, Laboratory Investigation.

[188]  Z. Zeng,et al.  Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[189]  R. Stephens,et al.  Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility , 2013, Oncogene.

[190]  P. Katsikis,et al.  Memory T cells need CD28 costimulation to remember. , 2009, Seminars in immunology.

[191]  Z. Zeng,et al.  Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NFkappaB and MAPKs signaling pathways. , 2007, Molecular immunology.

[192]  J. Imura,et al.  IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling , 2014, British Journal of Cancer.

[193]  A. Puig-Kröger,et al.  Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. , 2009, Cancer research.

[194]  Ji Xu,et al.  Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1 , 2014, Cancer science.

[195]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[196]  C. Mathieu,et al.  Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[197]  M. Hudson Human , 2018, Critical Theory and the Classical World.

[198]  KonstantinGaengel,et al.  Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis , 2009 .

[199]  Z. Zeng,et al.  HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis , 2016, Journal of Cancer.

[200]  M. Rubin,et al.  Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation , 2014, The American journal of surgical pathology.

[201]  F. Shanahan,et al.  The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand , 1996, The Journal of experimental medicine.

[202]  E. Jung,et al.  Galectin‐1 expression in cancer‐associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer , 2007, International journal of cancer.

[203]  C. Decaestecker,et al.  Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas. , 2009, Anticancer research.

[204]  Z. Zeng,et al.  Epstein–Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma , 2016, Clinical and Translational Oncology.

[205]  M. Manns,et al.  Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. , 2011, Blood.

[206]  I. Modlin,et al.  Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms. , 2016, Best practice & research. Clinical endocrinology & metabolism.

[207]  A. Olar,et al.  Biologic correlates and significance of axonogenesis in prostate cancer. , 2014, Human pathology.

[208]  F. Visseren,et al.  Obesity and Cancer: The Role of Dysfunctional Adipose Tissue , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[209]  Ishtiaq Rehman,et al.  Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A , 2007, The Prostate.

[210]  G. Muto,et al.  Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer , 2011, Oncogene.

[211]  Z. Zeng,et al.  AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis , 2015, Tumor Biology.

[212]  Shayn M Peirce,et al.  IFATS Collection: The Role of Human Adipose‐Derived Stromal Cells in Inflammatory Microvascular Remodeling and Evidence of a Perivascular Phenotype , 2008, Stem cells.

[213]  Ping Zhang,et al.  Intratumoral polymorphonuclear granulocyte is associated with poor prognosis in squamous esophageal cancer by promoting epithelial-mesenchymal transition. , 2015, Future oncology.

[214]  V. Barroca,et al.  Granulocyte colony‐stimulating factor off‐target effect on nerve outgrowth promotes prostate cancer development , 2015, International journal of cancer.

[215]  Daniel Öhlund,et al.  Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.

[216]  Z. Zeng,et al.  EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC , 2015, Oncotarget.

[217]  Z. Zeng,et al.  Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus , 2006, Genetics in Medicine.

[218]  M. Trojanowska,et al.  GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts. , 2008, Biochimica et biophysica acta.

[219]  Yao‐Hua Song,et al.  Epithelial–mesenchymal transition in breast cancer lines is mediated through PDGF‐D released by tissue‐resident stem cells , 2012, International journal of cancer.

[220]  Y. Hirata,et al.  Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. , 1997, Genomics.

[221]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[222]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[223]  Z. Zeng,et al.  The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature , 2016, Journal of Cancer.

[224]  L. Nie,et al.  VEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling , 2010, Circulation research.

[225]  M. Messi,et al.  Type-2 pericytes participate in normal and tumoral angiogenesis. , 2014, American journal of physiology. Cell physiology.

[226]  P. Handford,et al.  Crystallization and preliminary X-ray diffraction analysis of three EGF domains of EMR2, a 7TM immune-system molecule. , 2004, Acta crystallographica. Section D, Biological crystallography.

[227]  J. Rosenfeld,et al.  Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. , 2012, Blood.

[228]  C. Drake,et al.  Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. , 2012, Current opinion in immunology.

[229]  Donglei Zhang,et al.  Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. , 2003, Cancer research.

[230]  L. B. Kim,et al.  Dynamic Structure of Proteoglycans/Glycosaminoglycans in the Lungs of Mice with Chronic Granulomatous Inflammation , 2016, Bulletin of Experimental Biology and Medicine.

[231]  Ya Cao,et al.  Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. , 2007, Molecular immunology.

[232]  Y. Shang,et al.  Molecular Mechanisms Involved in the Growth Stimulation of Breast Cancer Cells by Leptin , 2004, Cancer Research.

[233]  J. M. De La Rosa,et al.  Hyperglycemia Enhances the Proliferation of Non-Tumorigenic and Malignant Mammary Epithelial Cells through Increased leptin/IGF1R Signaling and Activation of AKT/mTOR , 2013, PloS one.

[234]  Y Magnusson,et al.  TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer , 2013, Oncogene.

[235]  Guojun Chen,et al.  KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy. , 2016, Biomaterials.

[236]  Z. Zeng,et al.  LOC401317, a p53-Regulated Long Non-Coding RNA, Inhibits Cell Proliferation and Induces Apoptosis in the Nasopharyngeal Carcinoma Cell Line HNE2 , 2014, PloS one.

[237]  Z. Zeng,et al.  Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103 , 2016, Cell Death and Disease.

[238]  P. Hahnfeldt,et al.  Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. , 1994, Cancer research.

[239]  Z. Zeng,et al.  Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma , 2017, Journal of Cancer.

[240]  D. Porter,et al.  Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review , 2014, Breast Cancer Research and Treatment.

[241]  K. Tsao,et al.  Development of an ELISA for the detection of serum chromogranin A (CgA) in prostate and non-neuroendocrine carcinomas. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[242]  S. Segal,et al.  Regulation of interleukin 1 generation in immune‐activated fibroblasts , 1990, European journal of immunology.

[243]  R. Evans,et al.  A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response , 2013, Cell.

[244]  M. Matsumoto,et al.  A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth. , 2011, Cancer research.

[245]  Wei Xiong,et al.  TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer. , 2016, International journal of oncology.

[246]  Z. Zeng,et al.  Lactotransferrin: A candidate tumor suppressor—Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen‐activated protein kinase pathway , 2008, International journal of cancer.

[247]  J. Gimble,et al.  Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Triple Negative Breast Cancer Xenografts , 2014, PloS one.

[248]  D. Lübbers,et al.  Oxygen pressure in small lymphatics , 1976, Pflügers Archiv.

[249]  A. Bode,et al.  Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines , 2011, Cellular and Molecular Immunology.

[250]  D. Graves,et al.  Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingiva. , 1995, Journal of periodontology.

[251]  Z. Zeng,et al.  Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma , 2015, Tumor Biology.

[252]  C. Betsholtz,et al.  The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade. , 2010, Cancer research.

[253]  M. Schwartz,et al.  Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology , 2015, Nature Communications.

[254]  K. Tracey,et al.  HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. , 2014, Cancer research.

[255]  Sung-Hyun Kim,et al.  Adipose-derived stem cells induced EMT-like changes in H358 lung cancer cells. , 2013, Anticancer research.

[256]  Brian Seed,et al.  Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation , 2003, Nature Medicine.

[257]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[258]  R. Jensen,et al.  Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor. , 2013, Biochimica et biophysica acta.

[259]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[260]  R. Kalluri,et al.  Early role of Fsp1 in epithelial-mesenchymal transformation. , 1997, American journal of physiology. Renal physiology.

[261]  M. Goldring,et al.  Laminins and Nidogens in the Pericellular Matrix of Chondrocytes: Their Role in Osteoarthritis and Chondrogenic Differentiation. , 2016, The American journal of pathology.

[262]  D. Park,et al.  Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1α from human mesenchymal stem cells , 2010, Experimental & Molecular Medicine.

[263]  Z. Zeng,et al.  Long non-coding RNAs in cancer , 2012, Science China Life Sciences.

[264]  A. Galinier,et al.  Weight-dependent changes of immune system in adipose tissue: importance of leptin. , 2006, Experimental cell research.

[265]  Z. Zeng,et al.  Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2 , 2016, Tumor Biology.